Evidence map›Paper›PMID 22197887›Full record

ReviewMolecular and cellular endocrinology2012

Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly.

Heng-Yu Fan, Zhilin Liu, Lisa K Mullany, JoAnne S Richards

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Finishing the egg.Genetics · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of the Guanosine Nucleotide-Binding Protein in the Corpus Luteum.Animals : an open access journal from MDPI · 2021
    Review
  14. Frontiers in molecular biosciences · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. A high-resolution X chromosome copy-number variation map in fertile females and women with primary ovarian insufficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  19. Differential gene expression analysis of human cumulus cells.Clinical and experimental reproductive medicine · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Heng-Yu FanDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, United States.
Zhilin Liu
Lisa K Mullany
JoAnne S Richards
Baylor College of Medicine · US

Funding

TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MANCINI, MICHAEL A. · 1998 to 2013
$19.9M
REPRODUCTIVE BIOLOGY: REGULATORY MECHANISMST32HD007165 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI O'MALLEY, BERT W · 1985 to 2015
$5.6M
LH ACTION IN OVARIAN CELL DIFFERENTIATIONR37HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE S. · 1998 to 2007
$2.0M
LH ACTION IN OVARIAN CELL DIFFERENTIATIONR01HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1985 to 2013
$1.9M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
LH Action in Ovarian Cell DifferentiationR56HD016229 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 2008 to 2008
$326k
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
NICHD NIH HHS NIH-HD-07165NICHD NIH HHS NIH-HD-07495NICHD NIH HHS NIH-HD-16229NICHD NIH HHS P30 HD007495NICHD NIH HHS R01 HD016229NICHD NIH HHS R37 HD016229NICHD NIH HHS R56 HD016229NICHD NIH HHS T32 HD007165NICHD NIH HHS T32 HD007495NICHD NIH HHS U54 HD007495NICHD NIH HHS U54 (HD-07495-PROJECT 2)
6 · The paper itself

Abstract

This review summarizes studies providing evidence (1) that endogenous RAS activation regulates important physiological events during ovulation and luteinization (2) that expression of the mutant, active KRAS(G12D) in granulosa cells in vivo causes abnormal follicle growth arrest leading to premature ovarian failure and (3) that KRAS(G12D) expression in ovarian surface epithelial (OSE) cells renders them susceptible to the pathological outcome of transformation and tumor formation. These diverse effects of RAS highlight how critical its activation is linked to cell- and stage-specific events in the ovary that control normal processes and that can also lead to altered granulosa cell and OSE cell fates.

Indexed as

Enzyme ActivationAnimalsCarcinoma, Ovarian EpithelialFemaleGranulosa CellsHumansMitogen-Activated Protein KinasesMutation, MissenseNeoplasms, Glandular and EpithelialOvarian NeoplasmsOvaryOvulationras ProteinsMitogen-Activated Protein Kinasesras Proteins

Identifiers

PMID22197887
PMCPMC3327778
OpenAlexW2016312444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.